ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
98 hedge funds and large institutions have $109M invested in Endocyte, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 34 increasing their positions, 28 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
25% less call options, than puts
Call options by funds: $1.49M | Put options by funds: $1.98M
Holders
98
Holding in Top 10
–
Calls
$1.49M
Puts
$1.98M
Top Buyers
| 1 | +$5.42M | |
| 2 | +$1.43M | |
| 3 | +$960K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$350K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$295K |
Top Sellers
| 1 | -$1.62M | |
| 2 | -$999K | |
| 3 | -$991K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$839K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$531K |